Varro Receives $20 Million from Vitalik Buterin to Support Development of Cutting-Edge Pathogen Biosensor Technology Varro to enable improved pathogen detection worldwide by making its proprietary biosensor tech platform available via Open Source NEW YORK, ST. LOUIS and SINGAPORE -…
Technology developed by Washington University in St. Louis that detects SARS-CoV-2 and other viral, bacterial, and fungal pathogens in people and spaces in under 60 seconds Addressing new threats: In the event a new pathogenic threat emerges, Varro can create…
Scientists at Washington University in St. Louis have developed a breath test that quickly identifies those who are infected with the virus that causes COVID-19. The device requires only one or two breaths and provides results in less than a…
The scientific journal ACS Sensors published a report by Varro Life Science’s academic collaborators entitled “Rapid Direct Detection of SARS-CoV-2 Aerosols in Exhaled Breath at the Point of Care.” The research notes that “Our platform holds the potential to be adapted for…